Table 3 Annual decline in FVC% predicted by GORD variable
From: Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
GORD variable | Yes (95% CI) | No (95% CI) | p | ||
|---|---|---|---|---|---|
Antacid therapy | 4.0% | 3.3, 4.8% | 3.7% | 2.7, 4.7% | 0.614 |
GORD diagnosis | 4.6% | 3.5, 5.4% | 3.5% | 2.7, 4.4% | 0.162 |
Typical reflux symptoms | 4.0% | 3.0, 5.1% | 3.7% | 3.0, 4.4% | 0.612 |
FSSG> 8 | 4.5% | 3.5, 5.4% | 3.5% | 2.7, 4.4% | 0.153 |